The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Interferon Market Report By Type (Alpha, Beta, Gamma), By Disease Treatment (Hepatitis, Multiple Sclerosis, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11213981
April 2021
Report Formats: Electronic (PDF), MS EXCEL
Global Interferon Market Overview
The key driver impacting the interferon market is the rising prevalence of chronic diseases such as hepatitis-C, hepatitis-B, cancer, and multiple sclerosis. According to the National Center for Biotechnology Information (NCBI ), one in three adults suffers from multiple chronic conditions (MCCs). According to the World Health Organisation report, chronic disease accounts for 60% of the global disease burden by 2020. Cancer is the second most cause of death and accounts for 9.6 million deaths globally in 2018. According to the MS Trust, around 2,500,000 people have multiple sclerosis(MS) across the globe. Moreover, in the U.K. alone, the number of adults with MS has risen to 131,720. People with MS in the UK is increasing by 2.4% per year due to people with MS are living longer.
Moreover, an increase in R&D investments and technological advancements is also estimated to be an important determinant that adds growth to the market. The global demand for interferon is estimated to boom due to the growing use of interferon and antiretroviral and anti-malarial drugs in treating Covid-19 patients. The pandemic outbreak of the coronavirus positively impacted the interferon market. Ongoing trials have been initiated on various drug candidates, including interferon as potential therapeutic options for covid-19 treatment. The drug regulators, such as the Health Research Authority (HRA) and Medicines and Healthcare products Regulatory Agency (MHRA) have approved the initiation of trials assessing interferons.
Global Interferon Market Share by Region (Representative Graph)
However, the patent expiration of interferon drugs acts as may hamper the global medical thawing system industry in the long run. The current industry trend, such as a rise in funding, and technological advancements, and increasing product launches, is expected to provide beneficial market opportunities for the key players in the forecast years.
The global interferon market is vast, with a large number of international and local players. The key leaders follow various strategies to strengthen their market position, such as rising product portfolio, mergers, expansions, acquisitions, and product innovations to enlarge their market share at the global level. The report studies major key players of the global interferon market in detail, covering the company profile, product list, and financial information. The companies included in the report are Roche, Biosidus, PROBIOMED, Amega Biotech, RheinMinapharm Biogenetics, 3Sbio, ZydusCadila, Nanogen.
In this market research report, the market is segmented by type, disease treatment, and region.
Analysis By Type
By type segment, the report is categorized into alpha, beta, and Gama. The various types of interferon (IFN) have been used to treat these diseases, and critical development in treating some of these diseases recognized that the clinical effects of IFN drugs could be significantly enhanced by combining them with other drugs. For instance, IFN-a (interferon-alpha) combined with polyethylene glycol and ribavirin molecule has shown important improvements in virological response and with no harmful side effects. Studies revealed that nanoencapsulation of IFN-a within nanoparticles would enhance the oral bioavailability of this drug. Thus, the usage of interferons in combinational therapies and the emergence of novel drug delivery systems are anticipated to surge the market for interferon.
Analysis By Disease Treatment
By disease treatment segment, the global interferon market is divided into hepatitis, multiple sclerosis, others. Hepatitis dominated the market with the largest share in 2019. Hepatitis B and hepatitis C segment is a significant revenue generator and is estimated to remain dominant till 2025. As per the World Health Organization estimates, 325 million people worldwide live with hepatitis B and C. However, the growing prevalence of other diseases like cancer and multiple sclerosis is projected to bring some positive attributes to market growth. Ongoing research on the effective vaccine is foreseen to create growth opportunities.
Analysis, By Region
In the regional outlook of the global interferon market, North America dominates the market in the forecast period, followed by Europe and Asia-Pacific. North America led the market with over 33% share in 2019. The United States is a prime revenue generator in the global interferon market due to advanced treatment procedures. Asia Pacific is anticipated to show the highest CAGR during the forecast period. The expanding aging population, growing awareness about interferon therapy, and government initiatives to increase health care expenditure is forecasted to swell demand across the region.
Market Segmentation covered in the Report:
By Type
By Disease Treatment
By Region
The key driver impacting the interferon market is the rising prevalence of chronic diseases such as hepatitis-C, hepatitis-B, cancer, and multiple sclerosis. According to the National Center for Biotechnology Information (NCBI ), one in three adults suffers from multiple chronic conditions (MCCs). According to the World Health Organisation report, chronic disease accounts for 60% of the global disease burden by 2020. Cancer is the second most cause of death and accounts for 9.6 million deaths globally in 2018. According to the MS Trust, around 2,500,000 people have multiple sclerosis(MS) across the globe. Moreover, in the U.K. alone, the number of adults with MS has risen to 131,720. People with MS in the UK is increasing by 2.4% per year due to people with MS are living longer.
According to Value Market Research, the global medical thawing system market was valued at around USD xxx million in 2019 and is estimated to grow at a CAGR of about 2.15% during the forecast period of 2020-2026.
Moreover, an increase in R&D investments and technological advancements is also estimated to be an important determinant that adds growth to the market. The global demand for interferon is estimated to boom due to the growing use of interferon and antiretroviral and anti-malarial drugs in treating Covid-19 patients. The pandemic outbreak of the coronavirus positively impacted the interferon market. Ongoing trials have been initiated on various drug candidates, including interferon as potential therapeutic options for covid-19 treatment. The drug regulators, such as the Health Research Authority (HRA) and Medicines and Healthcare products Regulatory Agency (MHRA) have approved the initiation of trials assessing interferons.
Global Interferon Market Share by Region (Representative Graph)
However, the patent expiration of interferon drugs acts as may hamper the global medical thawing system industry in the long run. The current industry trend, such as a rise in funding, and technological advancements, and increasing product launches, is expected to provide beneficial market opportunities for the key players in the forecast years.
The global interferon market is vast, with a large number of international and local players. The key leaders follow various strategies to strengthen their market position, such as rising product portfolio, mergers, expansions, acquisitions, and product innovations to enlarge their market share at the global level. The report studies major key players of the global interferon market in detail, covering the company profile, product list, and financial information. The companies included in the report are Roche, Biosidus, PROBIOMED, Amega Biotech, RheinMinapharm Biogenetics, 3Sbio, ZydusCadila, Nanogen.
In this market research report, the market is segmented by type, disease treatment, and region.
Analysis By Type
By type segment, the report is categorized into alpha, beta, and Gama. The various types of interferon (IFN) have been used to treat these diseases, and critical development in treating some of these diseases recognized that the clinical effects of IFN drugs could be significantly enhanced by combining them with other drugs. For instance, IFN-a (interferon-alpha) combined with polyethylene glycol and ribavirin molecule has shown important improvements in virological response and with no harmful side effects. Studies revealed that nanoencapsulation of IFN-a within nanoparticles would enhance the oral bioavailability of this drug. Thus, the usage of interferons in combinational therapies and the emergence of novel drug delivery systems are anticipated to surge the market for interferon.
Analysis By Disease Treatment
By disease treatment segment, the global interferon market is divided into hepatitis, multiple sclerosis, others. Hepatitis dominated the market with the largest share in 2019. Hepatitis B and hepatitis C segment is a significant revenue generator and is estimated to remain dominant till 2025. As per the World Health Organization estimates, 325 million people worldwide live with hepatitis B and C. However, the growing prevalence of other diseases like cancer and multiple sclerosis is projected to bring some positive attributes to market growth. Ongoing research on the effective vaccine is foreseen to create growth opportunities.
Analysis, By Region
In the regional outlook of the global interferon market, North America dominates the market in the forecast period, followed by Europe and Asia-Pacific. North America led the market with over 33% share in 2019. The United States is a prime revenue generator in the global interferon market due to advanced treatment procedures. Asia Pacific is anticipated to show the highest CAGR during the forecast period. The expanding aging population, growing awareness about interferon therapy, and government initiatives to increase health care expenditure is forecasted to swell demand across the region.
Market Segmentation covered in the Report:
By Type
- Alpha
- Beta
- Gamma
By Disease Treatment
- Hepatitis
- Multiple Sclerosis
- Others
By Region
- North America
- Europe
- the Asia Pacific
- Latin America
- The Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . INTERFERON – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Type
3.7.2 By Disease Treatment
3.7.3 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL INTERFERON MARKET ANALYSIS BY TYPE
6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Alpha Market by Regions
6.6 Beta Market by Regions
6.5 Gamma Market by Regions
7 . GLOBAL INTERFERON MARKET ANALYSIS BY DISEASE TREATMENT
7.1 Overview by Disease Treatment
7.2 Historical and Forecast Data
7.3 Analysis by Disease Treatment
7.4 Hepatitis Market by Regions
7.5 Multiple Sclerosis Market by Regions
7.6 Others Market by Regions
8 . GLOBAL INTERFERON MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America
8.3.1. Overview, Historic and Forecast Data
8.3.2. North America By Segment
8.3.3. North America By Country
8.3.4. United State
8.3.5. Canada
8.3.6. Mexico
8.4. Europe
8.4.1. Overview, Historic and Forecast Data
8.4.2. Europe by Segment
8.4.3. Europe by Country
8.4.4. United Kingdom
8.4.5. France
8.4.6. Germany
8.4.7. Italy
8.4.8. Russia
8.4.9. Rest Of Europe
8.5. Asia Pacific
8.5.1. Overview, Historic and Forecast Data
8.5.2. Asia Pacific by Segment
8.5.3. Asia Pacific by Country
8.5.4. China
8.5.5. India
8.5.6. Japan
8.5.7. South Korea
8.5.8. Australia
8.5.9. Rest Of Asia Pacific
8.6. Latin America
8.6.1. Overview, Historic and Forecast Data
8.6.2. Latin America by Segment
8.6.3. Latin America by Country
8.6.4. Brazil
8.6.5. Argentina
8.6.6. Peru
8.6.7. Chile
8.6.8. Rest of Latin America
8.7. Middle East & Africa
8.7.1. Overview, Historic and Forecast Data
8.7.2. Middle East & Africa by Segment
8.7.3. Middle East & Africa by Country
8.7.4. Saudi Arabia
8.7.5. UAE
8.7.6. Israel
8.7.7. South Africa
8.7.8. Rest Of Middle East And Africa
9 . COMPETITIVE LANDSCAPE OF THE INTERFERON COMPANIES
9.1. Interferon Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF INTERFERON INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Roche
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products
10.3.4. Recent Developments
10.4. Biosidus
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products
10.4.4. Recent Developments
10.5. PROBIOMED
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products
10.5.4. Recent Developments
10.6. Amega Biotech
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products
10.6.4. Recent Developments
10.7. RheinMinapharm Biogenetics
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products
10.7.4. Recent Developments
10.8. 3Sbio
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products
10.8.4. Recent Developments
10.9. ZydusCadila
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products
10.9.4. Recent Developments
10.10. Nanogen
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products
10.10.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Type (USD MN)
- Alpha Market by Geography (USD MN)
- Beta Market by Geography (USD MN)
- Gamma Market by Geography (USD MN)
- Analysis Market by Disease Treatment (USD MN)
- Hepatitis Market by Geography (USD MN)
- Multiple Sclerosis Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Interferon Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Interferon Report
- Market Research Process
- Market Research Methodology
- Global Interferon Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Disease Treatment
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- Alpha Market by Geography (USD MN)
- Beta Market by Geography (USD MN)
- Gamma Market by Geography (USD MN)
- Global Market Analysis by Disease Treatment (USD MN)
- Hepatitis Market by Geography (USD MN)
- Multiple Sclerosis Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
ICT
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments